Retina Labs will be sponsoring and exhibiting at the upcoming 2022 RISE Star Ratings Master Class Conference in San Diego, December 13-15, 2022. We look forward to meeting HEDIS and STARS professionals to discuss how Retina Labs in-home diabetic eye exam gap closure model is helping health plans improve quality, STAR ratings and member experience.
For more information, click here.
Retina Labs will be sponsoring and exhibiting at the upcoming SSN 10th Annual Medicare Star Ratings & Quality Improvement Summit in New Orleans from December 3rd - December 5th, 2024.
Retina Labs will be sponsoring and exhibiting at the upcoming Rise STAR RATINGS MASTER CLASS conference in San Diego, December 13-15, 2022.
Retina Labs will be sponsoring and exhibiting at the upcoming Rise National conference in Colorado Springs, March 6-8, 2023.
Retina Labs is pleased to announce that it will sponsor exhibit at the upcoming America’s Health Insurance Plans (AHIP) Institute and Expo to be held in Nashville, TN June 19th to 21st, 2019. Known as the Essential Event for the Health Care Industry, AHIP’s Institute & Expo consistently delivers results for hundreds of solutions providers.
Retina Labs will be sponsoring and exhibiting at the upcoming 9th Annual Medicare Star Ratings & Quality Assurance Summit in Orlando, December December 6-8, 2023.
Retina Labs will be sponsoring and exhibiting at the upcoming Qualipalooza conference in Miami, June 20-23, 2023.
Retina Labs will be sponsoring and exhibiting at the upcoming 14th Annual HEDIS® & Quality Improvement Summit in Las Vegas.
Retina Labs will be sponsoring and exhibiting at the upcoming Rise National conference in Nashville, March 17-19, 2024.
Retina Labs is pleased to announce that it has been selected by the Ontario Telemedicine Network (OTN) as the solution for its provincial Teleophthalmology Program.
Retina Labs, a market innovator in teleophthalmology and virtual eye care solutions, has brought on Richard Pridham as its President and CEO and as an investor in the company.
SES Notify Fast-Tracks Delivery of Retina Labs’ Diabetic Retinopathy Diagnosis to Close Care Gaps and Reduce the $500M in Healthcare Spend
Dr. Marie Carole Boucher had had enough. Enough of seeing patients lose their sight because of a disease that was easily curable.
Maisonneuve Rosemont, one of Montreal’s largest hospitals centres, has chosen iVision®, Retina Labs industry leading teleophthalmology and virtual care platform.
The McGill Integrated University Health Network or Réseau Universitaire Intégré de Santé (known as “RUIS”), has chosen Retina Labs iVision Solution for its teleophthalmology program.
The First Nations of Quebec and Labrador Health and Social Services Commission have partnered with Retina Labs to provide screening for diabetic retinopathy.
Diabetic retinopathy is on the rise in Ontario. It is estimated that there are 1.2 million people with diabetes in Ontario, with 20% of those expected to experience vision loss.
In response to the COVID-19 pandemic, Retina Labs has announced its latest in teleophthalmology innovation with the introduction of a telemedicine-based e-consultation platform specially designed for eye health.
End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.
Retina Labs is excited to be one of a select group of companies mentioned in this report. Appearing in the category of Telemedicine / Telerefraction, Retina Labs has emerged a leader in the area of ocular telehealth.
November is officially Diabetic Eye Disease Awareness Month. Diabetic eye disease represents a group of eye conditions that affects those with diabetes.
End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.
In-home program offers Sentara members convenient access to a range of screenings including diabetic eye exams, HbA1c, kidney health assessments, colon cancer testing, and bone mineral density scans.
.jpg)
555 Marriott Drive, Suite 315, Nashville, TN 37214
Sales & Corporate Inquiries: (866) 344-2692
Fax: (866) 214-0724
6500 Trans-Canada Hwy, Suite 400, Pointe Claire, QC, H9R 0A5
Phone: (514) 344-2692
Fax: (866) 214-0724
